Q9978 – Netupitant 300 mg and palonosetron 0.5 mg

Long description

Netupitant 300 mg and palonosetron 0.5 mg

Short description

Netupitant palonosetron oral

Pricing indicator

51 Drugs

Medicare coverage

D Special coverage instructions apply

BETOS category

O1E Other drugs

Cross reference

J8655

Added

July 1, 2015

Last change

January 1, 2016 – No change

Termination date

December 31, 2015

Nearby Q codes

• Q9969 – Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose
• Q9970 – Injection, ferric carboxymaltose, 1mg
• Q9972 – Injection, epoetin beta, 1 microgram, (for esrd on dialysis)
• Q9973 – Injection, epoetin beta, 1 microgram, (non-esrd use)
• Q9974 – Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg
• Q9975 – Injection, factor viii fc fusion protein (recombinant), per iu
• Q9976 – Injection, ferric pyrophosphate citrate solution, 0.1 mg of iron
• Q9977 – Compounded drug, not otherwise classified
• Q9979 – Injection, alemtuzumab, 1 mg
• Q9980 – Hyaluronan or derivative, genvisc 850, for intra-articular injection, 1 mg
• Q9981 – Rolapitant, oral, 1 mg
• Q9982 – Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries
• Q9983 – Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries
• Q9984 – Levonorgestrel-releasing intrauterine contraceptive system (kyleena), 19.5 mg
• Q9985 – Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg
• Q9986 – Injection, hydroxyprogesterone caproate, (makena), 10 mg